Wheelchair use by patients with amyotrophic lateral sclerosis: a survey of user characteristics and selection preferences.

OBJECTIVES To determine wheelchair types and features that are most beneficial to patients with amyotrophic lateral sclerosis (ALS), to ascertain at what stage of disease and disability patients benefit from wheelchair use, and to pinpoint the differences in patient characteristics between the users of manual and motorized wheelchairs. DESIGN Internally generated questionnaire. SETTING A neuromuscular clinic. PATIENTS Forty-two patients (28 men, 14 women) with ALS who used wheelchairs and whose mean age was 53.9 years (range, 32-75yr). MAIN OUTCOME MEASURE Wheelchair users completed a 39-item survey. RESULTS At the time of the survey, the patients' mean Appel ALS rating scale total score was 84.5 (range, 48-138), indicating moderate disability. Forty-one patients reported that wheelchairs permitted them greater interaction in their communities; 33 were "very satisfied" with the positive impact of wheelchair use on their activity levels. Most users did not work and needed caregiver assistance for activities of daily living. The most desirable wheelchair features provide extra comfort (supports for the head, neck, trunk, extremities) and have improved maneuverability (lightweight frame, smaller wheelbase). Undesirable features are low sling backs and sling seats, nonremovable static leg rests, and large frames. No significant differences were reported between manual wheelchair users and motorized wheelchair users in terms of overall disease symptom severity, arm and leg strength, and bulbar function. However, motorized wheelchairs offer patients a greater sense of independence and an improved sense of well-being. CONCLUSION Information obtained directly from wheelchair users with ALS provided first-hand experience concerning the most and least desirable features of wheelchairs and may help other ALS patients make informed decisions when purchasing a wheelchair.

[1]  S H Appel,et al.  Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. , 1995, Brain : a journal of neurology.

[2]  M. Gaweł,et al.  Effect of recombinant human insulin-like growth factor-I on progression of ALS , 1997, Neurology.

[3]  David Porter,et al.  Wheelchair Users and Postural Seating: A Clinical Approach , 1998 .

[4]  M. Swash,et al.  The Pathology of Motor Neuron Disease , 1995 .

[5]  R. Sufit,et al.  Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) , 1999, Neurology.

[6]  E. Lai Therapeutic developments in amyotrophic lateral sclerosis. , 1999, Expert opinion on investigational drugs.

[7]  D. B. Williams,et al.  Motor neuron disease (amyotrophic lateral sclerosis). , 1991, Mayo Clinic proceedings.

[8]  Anita Perr,et al.  Elements of seating and wheeled mobility intervention , 1998 .

[9]  G. Smith,et al.  A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience , 1987, Annals of neurology.

[10]  D. Forshew,et al.  The economic impact of ALS , 1996, Neurology.

[11]  R. Sufit,et al.  Practice parameter: The care of the patient with amyotrophic lateral sclerosis (An evidence‐based review) , 1999, Muscle & nerve.

[12]  M. Swash,et al.  Motor Neuron Disease: The Clinical Syndrome , 1995 .

[13]  P. Andres,et al.  The natural history of motoneuron loss in amyotrophic lateral sclerosis , 1988, Neurology.